The effects of Ankaferd hemostat on preventing oral mucositis in colorectal cancer patients receiving chemotherapy

[1] Dekker E(2019)Colorectal cancer Lancet 394 1467-1480

[2] Tanis PJ(2007)Pathobiology of oral mucositis: novel insights and opportunities J Support Oncol 5 3-11

[3] Vleugels JLA(2015)Oral mucositis induced by anticancer therapies Curr Oral Heal Rep 2 202-221

[4] Sonis S(1999)Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: a potential ınterest for predicting 5-FU toxicity and determining optimal 5-FU dosage J Clin Oncol 17 1105-1110

[5] Al-Ansari S(2003)The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis Cancer 98 1531-1539

[6] Zecha JAEM(2013)Irsogladine maleate reduces the incidence of fluorouracil-based chemotherapy-induced oral mucositis Ann Oncol 24 1062-1066

[7] Barasch A(2012)A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy Supportive Care in Cancer 20 1797-1804

[8] Gamelin BE(2020)MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy Cancer 2020 4423-4431

[9] GueV DR(2015)Safety and efficacy of Ankaferd hemostat ( ABS ) in the chemotherapy-induced oral mucositis UHOD 25 166-171

[10] Elting LS(2008)Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper ® J Int Med Res 36 163-170

[1] Dekker E(2019)Colorectal cancer Lancet 394 1467-1480

[2] Tanis PJ(2007)Pathobiology of oral mucositis: novel insights and opportunities J Support Oncol 5 3-11

[3] Vleugels JLA(2015)Oral mucositis induced by anticancer therapies Curr Oral Heal Rep 2 202-221

[4] Sonis S(1999)Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: a potential ınterest for predicting 5-FU toxicity and determining optimal 5-FU dosage J Clin Oncol 17 1105-1110

[5] Al-Ansari S(2003)The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis Cancer 98 1531-1539

[6] Zecha JAEM(2013)Irsogladine maleate reduces the incidence of fluorouracil-based chemotherapy-induced oral mucositis Ann Oncol 24 1062-1066

[7] Barasch A(2012)A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy Supportive Care in Cancer 20 1797-1804

[8] Gamelin BE(2020)MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy Cancer 2020 4423-4431

[9] GueV DR(2015)Safety and efficacy of Ankaferd hemostat ( ABS ) in the chemotherapy-induced oral mucositis UHOD 25 166-171

[10] Elting LS(2008)Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper ® J Int Med Res 36 163-170